Search PDMR transactions

Notifier
Name of person with notification obligation
Per Wold-Olsen
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Per Wold-Olsen
Position
Chairman of the Board of Directors
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Oncopeptides AB
Issuer´s LEI code
549300J9WWQ5CBYQ1M77
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Oncopeptides AB SE0009414576 Acquisition 100,000 Quantity 9.0590713 SEK 18/02/2022 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Oncopeptides AB SE0009414576 Acquisition 18/02/2022 NASDAQ STOCKHOLM AB 100,000 (Quantity) 9.0590713 SEK
<< Back